Last reviewed · How we verify
NCT05196412
Screening of Cardiac Arrhythmias With Wrist-worn Aino ECG Cardiac Monitor
NA trial testing PulseOn Arrhythmia Monitor device in Arrhythmias, Cardiac in 250 participants. Completed in 10 July 2023.
10 July 2023
Quick facts
| Lead sponsor | PulseOn Oy |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | screening |
| Enrollment | 250 |
| Start date | 22 May 2022 |
| Primary completion | 10 July 2023 |
| Estimated completion | 10 July 2023 |
| Sites | 1 location across Finland |
Drugs / interventions tested
- PulseOn Arrhythmia Monitor device
Conditions studied
- Arrhythmias, Cardiac — all drugs for Arrhythmias, Cardiac →
- Atrial Fibrillation — all drugs for Atrial Fibrillation →
Sponsor
PulseOn Oy
Who can join
Adults 50 to 99, any sex, with Arrhythmias, Cardiac or Atrial Fibrillation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The study investigates the performance pf PulseOn Arrhythmia Monitor System that includes a wrist-worn device, which combines continuous optical heartbeat interval monitoring and intermittent ECG measurement, and a data management system used by healthcare professionals for data observation, in the detection of previously undiagnosed cardiac arrhythmias, especially atrial fibrillation.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Atrial fibrillation: epidemiology, screening and digital health.
Linz D, Gawalko M, Betz K, Hendriks JM, et al · · 2024 · cited 230× · PMID 38362546 · DOI 10.1016/j.lanepe.2023.100786
Verify or expand the search:
- PubMed search for NCT05196412
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Arrhythmias, Cardiac
Currently open trials in the same condition.
- NCT07276139 — PACEVALUE: Development of a Risk Score to Predict Pacing-Induced Cardiomyopathy in Patients Undergoing Pacemaker or ICD · active not recruiting
- NCT06954610 — Cardiac Assessment for Recurrent Stroke Risk Evaluation in Atrial Fibrillation · recruiting
- NCT06360939 — Radiotherapy vs Catheter Ablation for Ventricular Tachycardia in Structural Heart Disease · NA · recruiting
- NCT06890208 — Chronical Illness-related Limitations of the Ability to Cope With Rising Temperatures, Third Wave · recruiting
- NCT06358391 — To Compare and Evaluate the Efficacy and Safety Between TS-RF System and BRK Transseptal Needles Used for Transseptal Pu · NA · recruiting
Other PulseOn Oy trials
Trials by the same sponsor.
- NCT05008601 — Aino ECG Ambulatory Study · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05196412 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by PulseOn Oy
- Last refreshed: 27 August 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05196412.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing